Corporate Profile for MacroChem Corp., dated Sept. 1, 1995.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services See Information Systems. . These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine, CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International UMI United States Minor Outlying Islands (ISO Country code) UMI University of Miami UMI Universal Management Infrastructure (IBM) Data Courier, NewsBank, Information Access Company and many others. -0- Published date: Sept. 1, 1995 Company name: MacroChem Corp.
Address: 110 Hartwell Ave.
Lexington, Mass. 02173
Telephone No.: 617/862-4003 Chief Executive Officer: Alvin J. Karloff Chief Financial Officer: Edward L. Mann Investor Relations Contact: Alvin J. Karloff or Michael Kaiser Business number: 617/862-4003 Public Relations Contact: Alvin J. Karloff Business number: 617/862-4003 Trading symbol: MCHM Industry: Pharmaceutical, Biotechnology Company description: Formed 1985 -- MacroChem Corp.'s primary business is drug delivery -- the development and commercialization of advanced drug delivery systems for the transdermal delivery of enzyme, protein and drug compounds for therapeutic, over the counter and cosmetic applications. SEPA SEPA® Soft enhancer of percutaneous absorption Therapeutics A technology that enhances transdermal drug delivery. See Transcutaneous therapy. , MacroChem's worldwide patented compound accelerates the passage of drugs through the skin and other biomembranes. MacroDerm, the company's unique topical polymers provide a broad range of benefits to the cosmetic and OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). formulator through their ease of use and their desirable cosmetic characteristics. And MacroChem's PEV PEV Partido Ecologista os Verdes (The Greens, Portuguese ecological party) PEV Prediction Error Variance PEV Positive Effect Variegation , licensed from Italy's National Science Foundation (CNR See riser card. CNR - Communication and Network Riser ) is expected to provide broad benefits to the biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. industry by creating safe and stable protein formulations for therapeutic use. These technologies, protected by over 300 U.S. and foreign patents, form the backbone of MacroChem's drug delivery technology. CONTACT: MacroChem Corp. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion